These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28187877)

  • 1. Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.
    Kaito A; Kinoshita T; Shitara K; Shibasaki H; Nishida T
    Eur J Surg Oncol; 2017 Apr; 43(4):801-807. PubMed ID: 28187877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Totally Laparoscopic versus Open Gastrectomy for Gastric Cancer: a Matched Pair Analysis.
    Ludwig K; Schneider-Koriath S; Scharlau U; Steffen H; Möller D; Bernhardt J
    Zentralbl Chir; 2018 Apr; 143(2):145-154. PubMed ID: 29719906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis.
    Inokuchi M; Nakagawa M; Tanioka T; Okuno K; Gokita K; Kojima K
    Surg Endosc; 2018 Feb; 32(2):735-742. PubMed ID: 28726137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study.
    Kim IH; Park SS; Lee CM; Kim MC; Kwon IK; Min JS; Kim HI; Lee HH; Lee SI; Chae H
    Ann Surg Oncol; 2018 May; 25(5):1176-1183. PubMed ID: 29450755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Impact of Laparoscopic Surgery on the Long-term Survival of Advanced Gastric Cancer Patients With Regard to Facilitating Doublet Adjuvant Chemotherapy.
    Morino K; Yamamoto M; Yamanaka R; Iwasaki Y; Nakanishi N; Goto T; Tanaka H; Matsusue R; Machimoto T
    Anticancer Res; 2023 May; 43(5):2203-2209. PubMed ID: 37097653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?
    Fujitani K; Kurokawa Y; Takeno A; Endoh S; Ohmori T; Fujita J; Yamasaki M; Takiguchi S; Mori M; Doki Y;
    Gastric Cancer; 2018 May; 21(3):446-452. PubMed ID: 28965205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
    Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic Versus Open Gastrectomy for Cancer: A Western Center Cohort Study.
    Tsekrekos A; Klevebro F; Hayami M; Kamiya S; Lindblad M; Nilsson M; Lundell L; Rouvelas I
    J Surg Res; 2020 Mar; 247():372-379. PubMed ID: 31679797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy.
    Cho JH; Lim JY; Cho JY
    PLoS One; 2017; 12(10):e0186362. PubMed ID: 29040299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Laparoscopic Gastrectomy in Obese Patients (BMI≥30 kg/m2) with Gastric Cancer: A Comparison With Open Gastrectomy Regarding Short-term Outcomes.
    Chen K; Pan Y; Yu WH; Zheng XY; Zhu LH; Wang XF
    Surg Laparosc Endosc Percutan Tech; 2018 Feb; 28(1):e18-e23. PubMed ID: 29176372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.
    Shitara K; Chin K; Yoshikawa T; Katai H; Terashima M; Ito S; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Tsujinaka T
    Gastric Cancer; 2017 Jan; 20(1):175-181. PubMed ID: 26626800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
    Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
    Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
    Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of laparoscopic radical gastrectomy in gastric cancer patients with liver cirrhosis.
    Kim DJ; Park CH; Kim W; Jin HM; Kim JJ; Lee HH; Lee JH
    Surg Endosc; 2017 Oct; 31(10):3898-3904. PubMed ID: 28205032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.
    Feng D; Leong M; Li T; Chen L; Li T
    World J Surg Oncol; 2015 Jan; 13():11. PubMed ID: 25634099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.
    Hu Y; Huang C; Sun Y; Su X; Cao H; Hu J; Xue Y; Suo J; Tao K; He X; Wei H; Ying M; Hu W; Du X; Chen P; Liu H; Zheng C; Liu F; Yu J; Li Z; Zhao G; Chen X; Wang K; Li P; Xing J; Li G
    J Clin Oncol; 2016 Apr; 34(12):1350-7. PubMed ID: 26903580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis.
    Li Z; Liu Y; Hao Y; Bai B; Yu D; Zhao Q
    Surg Oncol; 2019 Mar; 28():167-173. PubMed ID: 30851895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.